Schroder Investment Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.07M Sell
92,281
-75,799
-45% -$4.17M ﹤0.01% 763
2025
Q1
$11.9M Sell
168,080
-50,884
-23% -$3.6M 0.01% 608
2024
Q4
$14.4M Buy
218,964
+89,515
+69% +$5.88M 0.01% 586
2024
Q3
$9.1M Sell
129,449
-100,150
-44% -$7.04M 0.01% 679
2024
Q2
$18.9M Sell
229,599
-20,494
-8% -$1.69M 0.02% 481
2024
Q1
$21.8M Sell
250,093
-20,324
-8% -$1.78M 0.03% 471
2023
Q4
$26.1M Buy
270,417
+141,694
+110% +$13.7M 0.03% 426
2023
Q3
$11.4M Sell
128,723
-10,082
-7% -$892K 0.02% 580
2023
Q2
$12M Sell
138,805
-1,054
-0.8% -$91.4K 0.02% 588
2023
Q1
$13.6M Buy
139,859
+876
+0.6% +$85.2K 0.02% 562
2022
Q4
$14.4M Buy
138,983
+30,867
+29% +$3.19M 0.02% 543
2022
Q3
$9.17M Buy
108,116
+95,959
+789% +$8.13M 0.02% 630
2022
Q2
$1.01M Buy
12,157
+5,194
+75% +$430K ﹤0.01% 1071
2022
Q1
$542K Buy
6,963
+2,041
+41% +$159K ﹤0.01% 1211
2021
Q4
$435K Buy
4,922
+95
+2% +$8.4K ﹤0.01% 1136
2021
Q3
$373K Sell
4,827
-283
-6% -$21.9K ﹤0.01% 1246
2021
Q2
$427K Buy
5,110
+1,170
+30% +$97.8K ﹤0.01% 1242
2021
Q1
$298K Buy
3,940
+77
+2% +$5.82K ﹤0.01% 1292
2020
Q4
$338K Sell
3,863
-78
-2% -$6.83K ﹤0.01% 1249
2020
Q3
$295K Sell
3,941
-342
-8% -$25.6K ﹤0.01% 1148
2020
Q2
$528K Sell
4,283
-535
-11% -$66K ﹤0.01% 995
2020
Q1
$398K Buy
+4,818
New +$398K ﹤0.01% 1011
2013
Q3
Sell
-13,644
Closed -$761K 1517
2013
Q2
$761K Buy
+13,644
New +$761K ﹤0.01% 1044